These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 32438411)
1. Shaking with fear: the role of noradrenaline in modulating resting tremor. Taylor NL; Müller EJ; Shine JM Brain; 2020 May; 143(5):1288-1291. PubMed ID: 32438411 [No Abstract] [Full Text] [Related]
2. The effects of adrenaline, noradrenaline, and isoprenaline on parkinsonian tremor. CONSTAS C J Neurol Neurosurg Psychiatry; 1962 May; 25(2):116-21. PubMed ID: 13880971 [No Abstract] [Full Text] [Related]
3. Action of adrenaline and noradrenaline on the tremor in Parkinson's disease. BARCROFT H; PETERSON E; SCHWAB RS Neurology; 1952; 2(2):154-60. PubMed ID: 14910821 [No Abstract] [Full Text] [Related]
4. Prevalence of a history of shaking in persons 65 years of age and older: diagnostic and functional correlates. Louis ED; Marder K; Cote L; Wilder D; Tang MX; Lantigua R; Gurland B; Mayeux R Mov Disord; 1996 Jan; 11(1):63-9. PubMed ID: 8771069 [TBL] [Abstract][Full Text] [Related]
5. The shaking patient. Diagnosis and management of tremor. McKinney AS Postgrad Med; 1977 Feb; 61(2):195-9. PubMed ID: 834691 [TBL] [Abstract][Full Text] [Related]
6. Noradrenaline, fear and extinction. Mason ST; Fibiger H Brain Res; 1979 Apr; 165(1):47-56. PubMed ID: 427586 [TBL] [Abstract][Full Text] [Related]
7. Effect of adrenaline, noradrenaline, atropine, and nicotine on some types of human tremor. Marshall J; Schnieden H J Neurol Neurosurg Psychiatry; 1966 Jun; 29(3):214-8. PubMed ID: 5937635 [No Abstract] [Full Text] [Related]
8. Effect of lesioning dopamine, noradrenaline and 5-hydroxytryptamine pathways on tremorine-induced tremor and rigidity. Dickinson SL; Slater P Neuropharmacology; 1982 Aug; 21(8):787-94. PubMed ID: 7121751 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of harmaline induced tremor by L-threo-3, 4-dihydroxyphenylserine, an L-norepinephrine precursor]. Yamazaki M; Ikeda Y; Ishikawa M; Inagaki C; Tanaka C Nihon Yakurigaku Zasshi; 1976 Apr; 72(3):363-9. PubMed ID: 986992 [TBL] [Abstract][Full Text] [Related]
10. Selective corticotropin-releasing factor type 1 receptor antagonist blocks conditioned fear-induced release of noradrenaline in the hypothalamic paraventricular nucleus of rats. Otagiri A; Wakabayashi I; Shibasaki T J Neuroendocrinol; 2000 Oct; 12(10):1022-6. PubMed ID: 11012844 [TBL] [Abstract][Full Text] [Related]
11. [Acute pharmacological test with clonidine for the tremor in patients with Parkinson disease]. Serrano-Dueñas M Rev Neurol; 2000 May 16-31; 30(10):910-3. PubMed ID: 10919184 [TBL] [Abstract][Full Text] [Related]
12. A role of central alpha-1 adrenergic mechanism in shaking stress-induced ACTH and noradrenaline secretion. Hirasawa R; Hashimoto K; Ota Z Acta Med Okayama; 1991 Jun; 45(3):141-5. PubMed ID: 1654019 [TBL] [Abstract][Full Text] [Related]
13. [A case presenting with both features of essential tremor and Parkinson tremor]. Inoue M; Mima T; Kojima Y; Satoi H; Makino F; Kanda M; Shibasaki H Rinsho Shinkeigaku; 2007 Jul; 47(7):413-8. PubMed ID: 17710884 [TBL] [Abstract][Full Text] [Related]
14. A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety. Hommers LG; Richter J; Yang Y; Raab A; Baumann C; Lang K; Schiele MA; Weber H; Wittmann A; Wolf C; Alpers GW; Arolt V; Domschke K; Fehm L; Fydrich T; Gerlach A; Gloster AT; Hamm AO; Helbig-Lang S; Kircher T; Lang T; Pané-Farré CA; Pauli P; Pfleiderer B; Reif A; Romanos M; Straube B; Ströhle A; Wittchen HU; Frantz S; Ertl G; Lohse MJ; Lueken U; Deckert J Transl Psychiatry; 2018 Oct; 8(1):226. PubMed ID: 30341278 [TBL] [Abstract][Full Text] [Related]
16. Noradrenaline transmission within the ventral bed nucleus of the stria terminalis is critical for fear behavior induced by trimethylthiazoline, a component of fox odor. Fendt M; Siegl S; Steiniger-Brach B J Neurosci; 2005 Jun; 25(25):5998-6004. PubMed ID: 15976089 [TBL] [Abstract][Full Text] [Related]
17. Peripheral catecholamines mediate certain responses to central cholinergic receptor stimulation by oxotremorine. Weinstock M; Zavadil AP; Kopin IJ Monogr Neural Sci; 1980; 7():138-45. PubMed ID: 7231435 [TBL] [Abstract][Full Text] [Related]
18. Modification of oxotremorine tremor and hypothermia by injections of drugs into the cerebral ventricles of the mouse. Doggett NS; O'Farrell SA Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):149-55. PubMed ID: 1012335 [TBL] [Abstract][Full Text] [Related]
19. TREMORINE: ITS EFFECT ON AMINES OF THE CENTRAL NERVOUS SYSTEM. FRIEDMAN AH; AYLESWORTH RJ; FRIEDMAN G Science; 1963 Sep; 141(3586):1188-90. PubMed ID: 14043364 [TBL] [Abstract][Full Text] [Related]
20. Diurnal variation of essential and physiological tremor. van Hilten JJ; van Dijk JG; Dunnewold RJ; van der Velde EA; Kemp B; van Brummelen P; van der Krogt JA; Roos RA; Buruma OJ J Neurol Neurosurg Psychiatry; 1991 Jun; 54(6):516-9. PubMed ID: 1880513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]